SCHEMBL15569016

SCHEMBL15569016

CN1CCN(c2ccc(CN(C(=O)C(F)(F)F)c3ccc(-c4nc5ccccc5n4Cc4ccccc4)cc3)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
BRD4 O60885 10/20 0.51
PDE6D O43924 2/20 0.45
ALDH2 P05091 1/20 0.45
ALDH3A1 P30838 1/20 0.45
TP53 P04637 2/20 0.45
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HRH3 Q9Y5N1 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15568175 0.92 BRD4 (0.48) ALDH1A1BRD4PDE6DALDH2ALDH3A1
SCHEMBL15568323 0.92 ALDH1A1 (0.52) ALDH1A1BRD4PDE6DALDH2ALDH3A1
SCHEMBL15568648 0.88 ALDH1A1 (0.61) ALDH1A1BRD4PDE6DALDH2ALDH3A1
SCHEMBL15568320 0.86 ALDH1A1 (0.70) ALDH1A1BRD4PDE6DALDH2ALDH3A1
SCHEMBL15568513 0.84 TP53 (0.48) ALDH1A1BRD4PDE6DALDH2ALDH3A1
SCHEMBL15567574 0.84 DRD2 (0.51) ALDH1A1BRD4PDE6DALDH2ALDH3A1
SCHEMBL15568269 0.82 ALDH1A1 (0.57) ALDH1A1BRD4PDE6DALDH2ALDH3A1
Trifluoroacetic Acid SCHEMBL15569018 0.80 BRD4 (0.50) BRD4MAPTHRH3
SCHEMBL15567956 0.79 ALDH1A1 (0.52) ALDH1A1BRD4PDE6DALDH2ALDH3A1
SCHEMBL15568475 0.79 ALDH1A1 (0.53) ALDH1A1BRD4PDE6DALDH2ALDH3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014027053-A1 BENZIMIDAZOLES FOR THE TREATMENT OF CANCER MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-02-20 WO claimed
WO-2014027053-A1 BENZIMIDAZOLES FOR THE TREATMENT OF CANCER MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-02-20 WO disclosed